Hutchmed receives USD15 million from AstraZeneca for Saffron progress
(Alliance News) - Hutchmed (China) Ltd on Monday said it has received USD15 million from AstraZeneca PLC as start-up activities for Saffron commenced.
Read more(Alliance News) - Hutchmed (China) Ltd on Monday said it has received USD15 million from AstraZeneca PLC as start-up activities for Saffron commenced.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Sharecast News) - Hutchmed China reported a 56% increase in total revenues in its full-year results on Thursday, to $356.1m (£266.17m), although its losses widened, as it announced the departure of its chief executive officer and the appointment of his replacement.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read moreFriday 25 February | |
Evraz PLC | Full Year Results |
IMI PLC | Full Year Results |
International Consolidated Airlines Group SA | Full Year Results |
Jupiter Fund Management PLC | Full Year Results |
Pearson PLC | Full Year Results |
Rightmove PLC | Full Year Results |
Monday 28 February | |
Associated British Foods PLC | Trading Statement |
BATM Advanced Communications Ltd | Full Year Results |
Bunzl PLC | Full Year Results |
CentralNic Group PLC | Full Year Results |
GlobalData PLC | Full Year Results |
Greencoat Renewables PLC | Full Year Results |
Grit Real Estate Income Group Ltd | Half Year Results |
Kitwave Group PLC | Full Year Results |
Kosmos Energy Ltd | Q4 Results |
Made Tech Group PLC | Half Year Results |
RHI Magnesita NV | Full Year Results |
Tuesday 1 March | |
abrdn PLC | Full Year Results |
Croda International PLC | Full Year Results |
Flutter Entertainment PLC | Full Year Results |
Hotel Chocolat Group PLC | Half Year Results |
Intertek Group PLC | Full Year Results |
Man Group PLC | Full Year Results |
PCI-PAL PLC | Half Year Results |
Quartix Technologies PLC | Full Year Results |
Reach PLC | Full Year Results |
Revolution Bars Group PLC | Half Year Results |
Rotork PLC | Full Year Results |
Travis Perkins PLC | Full Year Results |
Uniphar PLC | Full Year Results |
Vitec Group PLC | Full Year Results |
XP Power Ltd | Full Year Results |
Wednesday 2 March | |
Polymetal International PLC | Full Year Results |
Just Eat Takeaway.com NV | Full Year Results |
Vistry Group PLC | Full Year Results |
Nichols PLC | Full Year Results |
Hotel Chocolat Group PLC | Half Year Results |
Devro PLC | Full Year Results |
KRM22 PLC | Full Year Results |
Supermarket Income REIT PLC | Half Year Results |
Foxtons Group PLC | Full Year Results |
Persimmon PLC | Full Year Results |
Hiscox PLC | Full Year Results |
musicMagpie PLC | Full Year Results |
Vivo Energy PLC | Full Year Results |
Aviva PLC | Full Year Results |
Thursday 3 March | |
Admiral Group PLC | Full Year Results |
Avation PLC | Half Year Results |
Coats Group PLC | Full Year Results |
CRH PLC | Full Year Results |
Darktrace PLC | Half Year Results |
Dotdigital Group | Full Year Results |
Elementis PLC | Full Year Results |
Empiric Student Property PLC | Full Year Results |
Entain PLC | Full Year Results |
Franchise Brands PLC | Full Year Results |
Galliford Try Holdings PLC | Half Year Results |
Hansard Global PLC | Half Year Results |
Hutchmed (China) Ltd | Full Year Results |
ITV PLC | Full Year Results |
London Stock Exchange Group PLC | Full Year Results |
Meggitt PLC | Full Year Results |
Melrose Industries PLC | Full Year Results |
Mondi PLC | Full Year Results |
PageGroup PLC | Full Year Results |
Rentokil Initial PLC | Full Year Results |
Schroders PLC | Full Year Results |
Spire Healthcare Group PLC | Full Year Results |
Synthomer PLC | Full Year Results |
Taylor Wimpey PLC | Full Year Results |
Tritax Big Box REIT PLC | Full Year Results |
Tyman PLC | Full Year Results |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
Hutchmed starts new phase of probe on HMPL-453 as combination therapy
Read moreHutchmed begins phase one study for potential tumour treatment
Read moreTOP NEWS: Retailer ASOS now to be seen on London Main Market
Read moreHutchmed gains breakthrough therapy designation in China for HMPL-523
Read moreHutchmed begins phase one study for potential cancer treatment
Read moreHutchmed completes patient enrolment for cancer drug study
Read more(Sharecast News) - Hutchmed China announced on Friday that, following negotiations with the China National Healthcare Security Administration (NHSA), from 1 January the updated National Reimbursement Drug List (NRDL) will continue to include 'Elunate', or fruquintinib, and would now include 'Sulanda', or surufatinib.
Read moreTwo Hutchmed drugs included on China's state approved medicines list
Read moreHutchmed China shares rise on Orphathys and Tagrisso Phase 3 study
Read moreTOP NEWS: Astra transfers drug rights to Covis in USD270 million deal
Read more